Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cross-bridge Cycle

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Huntington Disease l: Introduction

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Proteinuria and gall bladder wall thickness as predictive indicators for dengue severity in pediatric patients.

Paediatrics & child health·2026

Same author

Evaluation of ChatGPT's Accuracy, Repeatability, and Reasoning Ability in Prosthodontics Education: A Cross-Sectional Comparative Study with Prosthodontists.

Journal of clinical and experimental dentistry·2026

Same author

A Novel Denture Teeth Arrangement Jig with Three-dimensional Printed Tooth Positioning Blocks.

Contemporary clinical dentistry·2025

Same author

Clinicodemographic and Biochemical Profile of Children with Dengue Infection.

Indian journal of pediatrics·2025

Same author

Parental Knowledge and Perceptions of the First Episode of Seizure in Children: A Single-Center Cross-Sectional Study.

Sage open pediatrics·2025

Same author

Adrenal Insufficiency after Steroid Therapy in Children with Steroid-Sensitive Nephrotic Syndrome: A Cross-sectional Study.

Indian journal of endocrinology and metabolism·2025

Search research articles

Related Experiment Video

Updated: Jul 1, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

Juvenile amyotrophic lateral sclerosis.

Anju Aggarwal¹, Shashiraj

¹Department of Pediatrics, University College of Medical Sciences, Guru Tegh Bahadur Hospital, Delhi, India. aanju@bol.net.in.

Indian Journal of Pediatrics

|March 29, 2006

Summary

Juvenile amyotrophic lateral sclerosis (JALS) is a rare motor neuron disease. This report details a sporadic JALS case with symptom onset at age four, highlighting diagnostic criteria.

Area of Science:

Neurology
Pediatric Neurology
Neurodegenerative Diseases

Background:

Juvenile amyotrophic lateral sclerosis (JALS) is a rare, progressive motor neuron disease affecting individuals under 25.
It presents with a combination of upper and lower motor neuron signs, impacting mobility and function.
JALS can be inherited (familial) or occur spontaneously (sporadic).

Observation:

This study reports a rare sporadic case of JALS in a 4-year-old child.
The patient exhibited characteristic upper and lower motor neuron signs.
The early onset presents unique diagnostic and management challenges.

Findings:

The case underscores the variability in JALS presentation and age of onset.
Diagnostic criteria for JALS were applied and reviewed in the context of this early-onset case.

More Related Videos

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)

Published on: February 22, 2011

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Related Experiment Videos

Last Updated: Jul 1, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)

Published on: February 22, 2011

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

Literature review provides context for this sporadic presentation.

Implications:

Early diagnosis of JALS is crucial for timely intervention and supportive care.
Understanding sporadic JALS cases expands knowledge of this rare disease.
Further research into JALS pathogenesis may reveal targeted therapeutic strategies.